Evidence map›Paper›PMID 39496818›Full record

ArticleVirchows Archiv : an international journal of pathology2024

Multifocal vascular neoplasm with an EWSR1::NFATC2 gene fusion and progression to epithelioid angiosarcoma - a case report.

Jože Pižem, Emanuela Boštjančič, Andrej Zupan, Vladka Salapura, Blaž Mavčič, Ana Blatnik, Olga Blatnik, Mojca Unk, Izidor Kern, Miha Švarc and 1 more

Erratum issuedAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jože PižemInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia. joze.pizem@mf.uni-lj.si.ORCID http://orcid.org/0000-0003-1207-2514
Emanuela BoštjančičInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.
Andrej ZupanInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.
Vladka SalapuraFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.
Blaž MavčičFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.
Ana BlatnikFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.
Olga BlatnikDepartment of Pathology, Institute of Oncology, Zaloška 2, 1000, Ljubljana, Slovenia.
Mojca UnkFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.
Izidor KernCytology and Pathology Laboratory, University Clinic Golnik, Golnik 36, 4204, Golnik, Slovenia.
Miha ŠvarcInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.
Alenka MatjašičInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.

Funding

Javna Agencija za Raziskovalno Dejavnost RS P3-0054
6 · The paper itself

Abstract

There is an emerging group of distinct vascular neoplasms with NFATC1/2 fusions, involving bones and soft tissues and often displaying focal epithelioid morphology, variable atypia of endothelial cells, predominantly vasoformative and in some cases focal solid growth. Although they may show aggressive local growth and may recur locally, malignant behaviour has not been documented. We present a case of a 35-year-old woman with multiple vascular neoplasms with a EWSR1::NFATC2 fusion involving the lungs, multiple bones (vertebra, femurs, tibia, pelvis) and probably the liver. The bone lesions were locally aggressive and recurred after surgical treatment. Nine years after the first manifestation, there was progression to an epithelioid angiosarcoma. The patient died 3 months after the diagnosis of epithelioid angiosarcoma with massive lung and liver involvement(metastases). In addition to the EWSR1::NFATC2 fusion, an activating PIK3CA gene mutation was identified in the angiosarcoma but not in the previously diagnosed bone tumours. To the best of our knowledge, this is the first documentation of malignant progression of a vascular neoplasm with NFATC1/2 fusion as well as visceral (lung) involvement.

Indexed as

Disease ProgressionHemangiosarcomaNFATC Transcription FactorsRNA-Binding Protein EWSAdultBone NeoplasmsClass I Phosphatidylinositol 3-KinasesFatal OutcomeFemaleGene FusionHumansMutationOncogene Proteins, FusionVascular NeoplasmsClass I Phosphatidylinositol 3-KinasesEWSR1 protein, humanNFATC2 protein, humanNFATC Transcription FactorsOncogene Proteins, FusionPIK3CA protein, humanRNA-Binding Protein EWSAngiosarcomaBone haemangiomaEWSR1::NFATC2 fusionPIK3CA mutation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.